An Endowed Chair in Mining-Related Lung Disease was established at the University of New Mexico (UNM) Health Sciences Center to help miners fight medical problems associated with the occupation. The project is the result of efforts from the UNM and the Miners’ Colfax Medical Center (MCMC), and it was…
https://www.youtube.com/watch?v=a9D2HUyud-k#t=27 In this video from Tom Nation, learn how to do the active cycle of breathing (ACBT). Tom is a sports therapist and a student physiotherapist finishing his masters at the University Of Essex. This breathing exercise will help you clear phlegm off your chest.
Idiopathic pulmonary fibrosis (or IPF) is a disease that has no known cause and, up until now, no known cure. There are several treatment options available to ease the symptoms, but there’s still no cure. Among the treatments available, there is lung transplant, which has been the most successful method…
According to research published in the journal Molecular Medicine Reports, blocking the reactive oxygen species-producing NOX1 enzyme prevented fibrotic changes in the lungs of mice exposed to irradiation, suggesting that pulmonary fibrosis caused by chest radiotherapy might be prevented by the use of specific blockers of the enzyme NOX1.
Pirfenidone (Esbriet) is an anti-inflammatory and anti-fibrotic drug that reduces inflammation and fibrosis simultaneously. Pirfenidone is an approved pharmacological agent for the treatment of idiopathic pulmonary fibrosis (IPF). In this video, shared by Demystifying Medicine, a youtube channel from McMaster…
Pulmonary fibrosis is a heart and lung condition that causes the thickening of the walls of the alveoli, scarring the alveoli and lung tissue. Because of this thickening and scarring, the amount of oxygen that can pass into the blood vessels is reduced causing PF patients to experience shortness…
Veracyte, Inc., presented new data indicating that its in-development genomic test, the Envisia classifier, has the potential to diagnosis idiopathic pulmonary fibrosis (IPF), distinguishing it from other interstitial lung diseases (ILD), and reduce the need for invasive diagnostic surgeries. The findings were presented by Dr. Giulia C. Kennedy, the company’s chief scientific officer,…
https://www.youtube.com/watch?v=OICp4hEHTMo Idiopathic pulmonary fibrosis is a severely debilitating condition that leaves patients struggling to breathe. IPF is the rare lung disease which claimed the lives of Hollywood actor, Marlon Brando, and international daredevil, Evel Knievel. Unfortunately, most patients who suffer from this deadly respiratory condition have never heard of it until…
1. Medication Currently, two medicines are approved by the U.S. Food and Drug Administration (FDA) for patients with idiopathic pulmonary fibrosis (IPF). Both Esbriet (pirfenidone) and Ofev (nintedanib) became available in 2014. Taken orally, Esbiret is an anti-inflammatory and an anti-fibrotic drug shown effective in reducing inflammation and fibrosis simultaneously.
Afferent Pharmaceuticals announced the results from the first cohort of a two-cohort Phase 2b study, revealing that the company’s AF-219, an orally available antagonist of the P2X3 receptors, significantly reduced cough frequency in patients with chronic cough, a commonly experienced symptom in people with idiopathic pulmonary fibrosis (IPF). P2X3 receptors are activated…
Get regular updates to your inbox.
